Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Accounts Payables: 2020-2024

Historic Accounts Payables for P3 Health Partners (PIII) over the last 4 years, with FY2024 value amounting to $8.4 million.

  • P3 Health Partners' Accounts Payables fell 2627.71% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year decrease of 2627.71%. This contributed to the annual value of $8.4 million for FY2024, which is 255.11% down from last year.
  • Per P3 Health Partners' latest filing, its Accounts Payables stood at $8.4 million for FY2024, which was down 255.11% from $8.7 million recorded in FY2023.
  • Over the past 5 years, P3 Health Partners' Accounts Payables peaked at $11.8 million during FY2020, and registered a low of $8.4 million during FY2024.
  • In the last 4 years, P3 Health Partners' Accounts Payables had a median value of $10.1 million in 2022 and averaged $10.1 million.
  • Per our database at Business Quant, P3 Health Partners' Accounts Payables crashed by 2494.37% in 2023 and then crashed by 255.11% in 2024.
  • Annual analysis of 4 years shows P3 Health Partners' Accounts Payables stood at $11.8 million in 2020, then dropped by 2.13% to $11.5 million in 2022, then fell by 24.94% to $8.7 million in 2023, then fell by 2.55% to $8.4 million in 2024.
  • Its last three reported values are $8.4 million in FY2024, $8.7 million for FY2023, and $11.5 million during FY2022.